These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25670260)

  • 1. Itraconazole therapy in a pancreatic adenocarcinoma patient: A case report.
    Lockhart NR; Waddell JA; Schrock NE
    J Oncol Pharm Pract; 2016 Jun; 22(3):528-32. PubMed ID: 25670260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rechallenge with cisplatin in a patient with pancreatic cancer who developed a hypersensitivity reaction to oxaliplatin. Is skin test useful in this setting?
    Elligers KT; Davies M; Sanchis D; Ferencz T; Saif MW
    JOP; 2008 Mar; 9(2):197-202. PubMed ID: 18326929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation recall gastritis secondary to erlotinib in a patient with pancreatic cancer.
    Graziani C; Hegde S; Saif MW
    Anticancer Res; 2014 Dec; 34(12):7339-43. PubMed ID: 25503169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: Proton pump inhibitor drug-related problem in pancreatic cancer patient unmasks pancreatic enzyme insufficiency.
    Giani J; Chambers CR; Sawyer MB
    J Oncol Pharm Pract; 2022 Mar; 28(2):457-461. PubMed ID: 34565254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma: improved efficacy compared with gemcitabine-based regimen.
    Yoo C; Kang J; Kim KP; Lee JL; Ryoo BY; Chang HM; Lee SS; Park DH; Song TJ; Seo DW; Lee SK; Kim MH; Park JH; Hwang DW; Song KB; Lee JH; Kim SC
    Oncotarget; 2017 Jul; 8(28):46337-46347. PubMed ID: 28564637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer.
    Shaib WL; Ip A; Cardona K; Alese OB; Maithel SK; Kooby D; Landry J; El-Rayes BF
    Oncologist; 2016 Feb; 21(2):178-87. PubMed ID: 26834159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial infusion chemotherapy for the patient of unresectable pancreatic carcinoma with multiple liver metastases: a case report.
    Fujii M; Miyake H; Sasaki K; Takagi T; Takamura K; Tashiro S
    J Med Invest; 2003 Aug; 50(3-4):199-202. PubMed ID: 13678391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neoadjuvant FOLFIRINOX for Unresectable Adenocarcinoma of the Pancreas - A Case Report].
    Ochiai T; Inoue H; Nakatsuji H; Watanabe N; Yoshiyama A; Ito H; Toma A; Nakamura K
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1349-1351. PubMed ID: 29394630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advancements in the management of pancreatic cancer: 2013.
    Saif MW
    JOP; 2013 Mar; 14(2):112-8. PubMed ID: 23474549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does erlotinib restore chemosensitivity to chemotherapy in pancreatic cancer? A case series.
    Saif MW
    Anticancer Res; 2011 Mar; 31(3):1039-42. PubMed ID: 21498735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. African histoplasmosis: therapeutic efficacy of itraconazole.
    Velho GC; Cabral JM; Massa A
    J Eur Acad Dermatol Venereol; 1998 Jan; 10(1):77-80. PubMed ID: 9552764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Level of evidence for therapeutic drug monitoring of itraconazole].
    Charles M; Le Guellec C; Richard D; Libert F;
    Therapie; 2011; 66(2):103-8. PubMed ID: 21635856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic carcinoma with brain metastases: case report and literature review.
    El Kamar FG; Jindal K; Grossbard ML; Mizrachi HH; Kozuch PS
    Dig Liver Dis; 2004 May; 36(5):355-60. PubMed ID: 15191206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term survival on S-1 monotherapy in a patient with recurrent stage IV pancreatic cancer.
    Alsamarai S; Zergebel C; Zhang J; Furuie T; Urrea PD; Saif MW
    JOP; 2008 Mar; 9(2):185-91. PubMed ID: 18326927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current perspectives on locally advanced pancreatic cancer.
    Czito BG; Willett CG; Clark JW; Fernandez Del Castillo C
    Oncology (Williston Park); 2000 Nov; 14(11):1535-45; discussion 1546, 1549-52. PubMed ID: 11125940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated gastrointestinal histoplasmosis: case report and review of the literature.
    Jain S; Koirala J; Castro-Pavia F
    South Med J; 2004 Feb; 97(2):172-4. PubMed ID: 14982268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cetuximab: still an option in the treatment of pancreatic cancer?
    Faloppi L; Andrikou K; Cascinu S
    Expert Opin Biol Ther; 2013 May; 13(5):791-801. PubMed ID: 23560505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete pathological response following neoadjuvant FOLFIRINOX in borderline resectable pancreatic cancer - a case report and review.
    Gostimir M; Bennett S; Moyana T; Sekhon H; Martel G
    BMC Cancer; 2016 Oct; 16(1):786. PubMed ID: 27724927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Types of pancreatic cancer in EUS-FNA and chemotherapy.
    Ulla JL; Martinez MA; Paz-Esquete J; Garcia-Arroyo R; Dominguez-Comesaña E; Vazquez-Astray E
    Am J Ther; 2011; 18(2):101-6. PubMed ID: 20019588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful discontinuation of secondary prophylaxis for histoplasmosis after highly active antiretroviral therapy.
    Sun HY; Chen MY; Hsieh SM; Hung CC; Chang SC
    J Formos Med Assoc; 2004 Jul; 103(7):546-8. PubMed ID: 15318277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.